NAVB - Navidea chief medical officer steps down; hires G2G Ventures as consultants

2023-03-31 05:00:30 ET

• Navidea Biopharmaceuticals ( NYSE: NAVB ) said Michael Rosol stepped down as chief medical officer and the company has hired G2G Ventures as executive consultants to help with its growth plans.
• The company noted that the chief medical officer's role will be assumed by existing leadership with help from G2G.
• Rosol, who is leaving to pursue other opportunities, will provide transition consulting services to the company.
• Navidea noted that G2G will help with growth strategies in business development and operations, enhancing financial reporting capability, and for effective investor communications.
• "We are eager to partner with Navidea to bring their underappreciated technology and assets to the forefront," said G2G Owner and Founder Jason Myers.

For further details see: